raremaprare-disease reference indexOrphadata 2026-06-23 · HPO 2026-09-01
ORPHA:673

Malaria

Type
Disease
Group
Disorder
Inheritance
Not applicable
Age of onset
All ages
Status
active

A life-threatening parasitic disease caused by <i>Plasmodium</i> (<i>P. </i>) parasites that are transmitted by <i>Anophles</i> mosquito bites to humans and is typically clinically characterized by attacks of fever, headache, chills and vomiting.

1

Names in Orphadata languages

12 of 12 languages
LangNameSynonyms
enMalaria
frPaludismeMalaria
deMalaria
esMalariaPaludismo
itMalaria
nlMalaria
ptMalária
plMalaria
csMalárie
ukМалярія
zh疟疾
trSıtma

Definition in:

2

Cross-references

qualifier = Orphanet mapping relation
SourceCodeQualifierICD relationValidation
OMIM611162Evalidated
ICD-10B50.0BTNTspecificvalidated
ICD-10B50.8BTNTspecificvalidated
ICD-10B50.9BTNTspecificvalidated
ICD-10B51.0BTNTspecificvalidated
ICD-10B51.8BTNTspecificvalidated
ICD-10B51.9BTNTspecificvalidated
ICD-10B52.0BTNTspecificvalidated
ICD-10B52.8BTNTspecificvalidated
ICD-10B52.9BTNTspecificvalidated
ICD-10B53.0BTNTspecificvalidated
ICD-10B53.1BTNTspecificvalidated
ICD-10B53.8BTNTspecificvalidated
ICD-10B54BTNTspecificvalidated
ICD-111F40BTNTspecificvalidated
ICD-111F41BTNTspecificvalidated
ICD-111F42BTNTspecificvalidated
ICD-111F43BTNTspecificvalidated
ICD-111F44BTNTspecificvalidated
ICD-111F45BTNTspecificvalidated
MONDO0005136Evalidated
MeSHD008288Evalidated
UMLSC0024530Evalidated
GARD6961Evalidated
MedDRA10025487Evalidated

E exact · NTBT this ORPHAcode is narrower than the target · BTNT broader than the target · ND not decided.

3

Classification

Preferential parent (Orphanet linearisation):

Parents in the classifications (1):

No children.

4

Genes

0 direct

Orphanet records no gene directly on this code.

5

Prevalence and incidence

31 records
TypeClassValueAreaQualificationValidationSource
Point prevalence1-9 / 100 0003 / 100 000EuropeValue and classValidatedEuropean Medicines Agency2015[OTHER]
Annual incidence1-5 / 10 00012 / 100 000FranceValue and classNot yet validatedORPHANET
Annual incidence6-9 / 10 00073 / 100 000WorldwideValue and classNot yet validatedORPHANET
Annual incidence1-9 / 100 0001.2 / 100 000EuropeValue and classValidatedEuropean Centre for Disease prevention and Control 2013-2017[OTHER]
Annual incidence1-9 / 1 000 0000.8 / 100 000AustriaValue and classValidatedEuropean Centre for Disease prevention and Control 2013-2017[OTHER]
Annual incidence1-9 / 100 0002.1 / 100 000BelgiumValue and classValidatedEuropean Centre for Disease prevention and Control 2011-2015[OTHER]
Annual incidence1-9 / 1 000 0000.16 / 100 000BulgariaValue and classValidatedEuropean Centre for Disease prevention and Control 2013-2017[OTHER]
Annual incidence1-9 / 1 000 0000.1 / 100 000CroatiaValue and classValidatedEuropean Centre for Disease prevention and Control 2013-2017[OTHER]
Annual incidence1-9 / 1 000 0000.52 / 100 000CyprusValue and classValidatedEuropean Centre for Disease prevention and Control 2013-2017[OTHER]
Annual incidence1-9 / 1 000 0000.32 / 100 000Czech RepublicValue and classValidatedEuropean Centre for Disease prevention and Control 2013-2017[OTHER]
Annual incidence1-9 / 1 000 0000.2 / 100 000EstoniaValue and classValidatedEuropean Centre for Disease prevention and Control 2013-2017[OTHER]
Annual incidence1-9 / 1 000 0000.74 / 100 000FinlandValue and classValidatedEuropean Centre for Disease prevention and Control 2013-2017[OTHER]
Annual incidence1-9 / 1 000 0000.68 / 100 000GreeceValue and classValidatedEuropean Centre for Disease prevention and Control 2013-2017[OTHER]
Annual incidence1-9 / 1 000 0000.14 / 100 000HungaryValue and classValidatedEuropean Centre for Disease prevention and Control 2013-2017[OTHER]
Annual incidence1-9 / 100 0001.7 / 100 000IrelandValue and classValidatedEuropean Centre for Disease prevention and Control 2013-2017[OTHER]
Annual incidence1-9 / 1 000 0000.18 / 100 000LatviaValue and classValidatedEuropean Centre for Disease prevention and Control 2013-2017[OTHER]
Annual incidence1-9 / 1 000 0000.22 / 100 000LithuaniaValue and classValidatedEuropean Centre for Disease prevention and Control 2013-2017[OTHER]
Annual incidence1-9 / 1 000 0000.84 / 100 000LuxembourgValue and classValidatedEuropean Centre for Disease prevention and Control 2013-2017[OTHER]
Annual incidence1-9 / 100 0001.54 / 100 000MaltaValue and classValidatedEuropean Centre for Disease prevention and Control 2013-2017[OTHER]
Annual incidence1-9 / 100 0001.84 / 100 000NetherlandsValue and classValidatedEuropean Centre for Disease prevention and Control 2013-2017[OTHER]
Annual incidence<1 / 1 000 0000.08 / 100 000PolandValue and classValidatedEuropean Centre for Disease prevention and Control 2013-2017[OTHER]
Annual incidence1-9 / 100 0001.44 / 100 000PortugalValue and classValidatedEuropean Centre for Disease prevention and Control 2013-2017[OTHER]
Annual incidence1-9 / 1 000 0000.16 / 100 000RomaniaValue and classValidatedEuropean Centre for Disease prevention and Control 2013-2017[OTHER]
Annual incidence<1 / 1 000 0000.06 / 100 000SlovakiaValue and classValidatedEuropean Centre for Disease prevention and Control 2013-2017[OTHER]
Annual incidence1-9 / 1 000 0000.28 / 100 000SloveniaValue and classValidatedEuropean Centre for Disease prevention and Control 2013-2017[OTHER]
Annual incidence1-9 / 100 0001.5 / 100 000SpainValue and classValidatedEuropean Centre for Disease prevention and Control 2013-2017[OTHER]
Annual incidence1-9 / 100 0001.88 / 100 000SwedenValue and classValidatedEuropean Centre for Disease prevention and Control 2013-2017[OTHER]
Annual incidence1-9 / 100 0002.38 / 100 000United KingdomValue and classValidatedEuropean Centre for Disease prevention and Control 2013-2017[OTHER]
Annual incidence1-9 / 100 0001.62 / 100 000NorwayValue and classValidatedEuropean Centre for Disease prevention and Control 2013-2017[OTHER]
Annual incidence1-9 / 100 0001.62 / 100 000DenmarkValue and classValidatedEuropean Centre for Disease prevention and Control 2013-2017[OTHER]
Annual incidence1-9 / 1 000 0000.75 / 100 000IcelandValue and classValidatedEuropean Centre for Disease prevention and Control 2016-2017[OTHER]

Value is Orphadata's ValMoy: the mean estimate per 100 000 for prevalence and incidence, the number of cases or families for case reports.

6

HPO phenotypes

16 annotations · validated 2017-01-25
HPOTerm (as annotated by Orphanet)Diagnostic
Very frequent (99-80%)
HP:0001919Acute kidney injury
HP:0001903Anemia
HP:0011227Elevated circulating C-reactive protein concentration
HP:0001945Fever
HP:0002315Headache
HP:0002011Morphological central nervous system abnormality
HP:0002017Nausea and vomiting
Frequent (79-30%)
HP:0001871Abnormality of blood and blood-forming tissues
HP:0100543Cognitive impairment
HP:0002141Gait imbalance
HP:0002904Hyperbilirubinemia
HP:0003326Myalgia
HP:0004372Reduced consciousness
HP:0002098Respiratory distress
HP:0001873Thrombocytopenia
Occasional (29-5%)
HP:0000488Retinopathy

Run the differential on the 7 obligate / very frequent terms

Annotation source: 27175507[PMID]

7

Sources for this card